Tool: DupCheckTool: DupCheck is a web-based tool to screen for duplicate patients in clinical trials within and across studies, sponsors and therapeutic areas. Please visit our "Tools" page for more information.

Project FlyerProject Flyer

Click here to download 
the NEWMEDS project flyer! 

consortium teaser

Project Office Project Office Annual PGB and WP Leads Meetings Annual PGB and WP Leads Meetings Project Governance Project Governance Funding Mechanisms Funding Mechanisms

  Members Area

IMI | The Innovative Medicines Initiative
EFPIA | European Federation of Pharmaceutical Industries and Associations

deCODE genetics

deCODE genetics
Sturlugata 8


Participant's Lead

Dr. Hreinn Stefánsson Dr. Hreinn Stefánsson
Heads of CNS division 
E-Mail to Dr. Hreinn Stefánsson Contact  

Institute Presentation

deCODE genetics is a biopharmaceutical company applying its discoveries in human genetics to develop drugs and diagnostics for common diseases. deCODE is a global leader in gene discovery - its population approach and resources have enabled it to isolate key genes contributing to major public health challenges from cardiovascular disease to cancer. The company’s genotyping capacity is now one of the highest in the world. deCODE genetics has a large population-based biobank containing whole blood and DNA samples with extensive relevant phenotypic information from around 120.000 Icelanders. In the company’s work in more than 50 disease projects, deCODE’s statistical and informatics departments have established themselves as leaders in data processing and analysis.
deCODE genetics is widely recognized as a centre of excellence in genetic research. The deCODE team has an outstanding record of successes, as witnessed by numerous high-impact publications, including in the study of schizophrenia.

09 Islensk Erfdagreining ehf